down arrow

Morepen Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE083A01026
  • NSEID: MOREPENLAB
  • BSEID: 500288
INR
50.25
2.13 (4.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 31.04 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Cipla
Sun Pharma.Inds.
Torrent Pharma
Alembic
Morepen Labs.
Senores Pharma.
Mankind Pharma
Indoco Remedies
Zota Health Care
Suven Life Scie.
Why is Morepen Laboratories Ltd ?
1
Flat results in Dec 24
  • PBT LESS OI(Q) At Rs 29.87 cr has Fallen at -27.0 %
  • PAT(Q) At Rs 26.69 cr has Fallen at -18.7 %
  • PBDIT(Q) Lowest at Rs 35.51 cr.
2
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 19-Feb-25 and has generated -3.08% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Morepen Labs. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Morepen Labs.
8.3%
0.16
54.09%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
15.38%
EBIT Growth (5y)
37.62%
EBIT to Interest (avg)
20.67
Debt to EBITDA (avg)
0.19
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.30
Tax Ratio
26.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.87%
ROCE (avg)
16.10%
ROE (avg)
14.15%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
21
Industry P/E
33
Price to Book Value
2.37
EV to EBIT
15.71
EV to EBITDA
13.83
EV to Capital Employed
2.59
EV to Sales
1.40
PEG Ratio
0.38
Dividend Yield
NA
ROCE (Latest)
17.65%
ROE (Latest)
11.82%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
PAT(9M)

At Rs 97.71 cr has Grown at 43.95 %

ROCE(HY)

Highest at 16.23 %

DEBTORS TURNOVER RATIO(HY)

Highest at 5.86 times

-10What is not working for the Company
PBT LESS OI(Q)

At Rs 29.87 cr has Fallen at -27.0 %

PAT(Q)

At Rs 26.69 cr has Fallen at -18.7 %

PBDIT(Q)

Lowest at Rs 35.51 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 7.84%

EPS(Q)

Lowest at Rs 0.49

Loading Valuation Snapshot...
Here's what is working for Morepen Labs.
Debtors Turnover Ratio- Half Yearly
Highest at 5.86 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Morepen Labs.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 29.87 cr has Fallen at -27.0 %
over average PBT of the previous four quarters of Rs 40.92 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 26.69 cr has Fallen at -18.7 %
over average PAT of the previous four quarters of Rs 32.82 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 35.51 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 7.84%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 29.87 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.49
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Non Operating Income - Quarterly
Highest at Rs 5.34 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income